Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05666739 · ClinicalTrials.gov registry record

NIEHS Repository of Stored Biological Samples for Future Use

A clinical trial of Normal Physiology, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT05666739: Recruiting study of Normal Physiology, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT05666739 is a study of Normal Physiology that is actively recruiting participants, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 2,000 participants, above the 1,213-participant average among 25 other Normal Physiology trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05666739, a study of Normal Physiology, is actively recruiting participants, sponsored by National Institute of Environmental Health Sciences (NIEHS).

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

Background: Laboratory tests that use blood and urine can provide a great deal of information about human health and disease. To develop even better tests and to improve the ways samples are handled for testing researchers need to experiment with samples from healthy people. Objective: This natural history study will collect blood and urine from healthy people. The samples will build a repository that will be used for all kinds of research. Eligibility: Healthy people aged 18 years or older. Design: Participants will have 1 study visit. The visit will last up to 2 hours. Participants will be screened. They will answer questions about their health history. They will list any medications they take. They will consent to donate samples for research and future use: Blood: Up to 4.5 tablespoons of blood may be collected from a needle inserted into a vein. Urine: Participants will be given a sterile container to provide a sample. Some participants may be asked to provide other types of samples. Some participants may be asked to provide new samples if their first ones are depleted.

Primary Outcome

To build a repository for approved investigators to access stored biological samples for the following: developing and testing specific laboratory assays, to maintain freezer and specimen handling quality control, to have blinded quality control specimens for testing labs, and to assess exposure variability over time.

Conditions Studied

Study Locations (1)

North Carolina

  • NIEHS Clinical Research Unit (CRU) - Research Triangle Park

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-07-15
Est. Completion 2032-07-19

What NCT05666739 shows while recruiting

NCT05666739 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,213-participant average among 25 other Normal Physiology trials with a reported enrollment target (65% higher).

The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 0 interventions.

NCT05666739 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05666739 about?

NCT05666739 is a clinical study titled "NIEHS Repository of Stored Biological Samples for Future Use". Background: Laboratory tests that use blood and urine can provide a great deal of information about human health and disease. To develop even better tests and to improve the ways samples are handled for testing researchers need to experiment with samples from healthy people. Objective: This natur...

What is the current status of trial NCT05666739?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-07-15. Estimated completion is 2032-07-19.

What conditions does trial NCT05666739 study?

This clinical trial studies the following conditions: Normal Physiology.

Who is sponsoring clinical trial NCT05666739?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05666739 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Physiology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05666739's enrollment target sits among peer trials

2,000 4th of 25 higher than 21 of 25 other Normal Physiology trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Normal Physiology trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05666739, the US trial registry maintained by the National Library of Medicine. NCT05666739 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.